background
use
sequenc
independ
method
combin
next
gener
sequenc
identif
purpos
clinic
sampl
appear
promis
excit
result
achiev
understand
unexplain
infect
one
sequenc
independ
method
viru
discoveri
base
cdna
amplifi
fragment
length
polymorph
vidisca
capabl
identifi
virus
would
remain
unidentifi
standard
diagnost
cell
cultur
method
vidisca
normal
combin
next
gener
sequenc
howev
set
simplifi
vidisca
use
case
next
gener
sequenc
possibl
stool
sampl
patient
unexplain
acut
flaccid
paralysi
show
cytopath
effect
rhabdomyosarcoma
cell
andor
mous
cell
use
test
effici
method
character
virus
vidiscaposit
sampl
amplifi
sequenc
gene
specif
primer
result
simplifi
vidisca
detect
seven
virus
proport
eukaryot
viral
sequenc
sampl
rang
human
enteroviru
human
parechoviru
human
astroviru
probabl
recombin
identifi
phylogenet
analysi
base
region
demonstr
human
enterovirus
diverg
isol
circul
commun
conclus
data
support
simplifi
vidisca
protocol
effici
identifi
unrecogn
virus
grown
cell
cultur
low
cost
limit
time
without
need
advanc
technic
expertis
also
complex
data
interpret
avoid
thu
method
use
power
diagnost
tool
limit
resourc
redesign
routin
diagnost
might
lead
addit
detect
previous
undiagnos
virus
clinic
sampl
patient
identif
character
virus
clinic
sampl
essenti
compon
commun
health
monitor
system
divers
rang
convent
molecular
base
diagnost
assay
wide
use
detect
pathogen
convent
assay
like
electron
microscopi
cell
cultur
immunolog
method
success
use
identif
virus
mani
occas
method
fail
detect
etiolog
agent
clinic
sampl
due
poor
sensit
cross
reactiv
therefor
molecular
assay
like
polymeras
chain
reaction
pcr
univers
primer
pcr
pan
viral
microarray
cdna
librari
immunoscreen
substitut
hybrid
use
detect
unknown
virus
method
alway
proven
use
due
increas
divers
viral
genom
low
viral
load
clinic
sampl
presenc
varieti
organ
singl
specimen
therefor
need
develop
improv
econom
diagnost
tool
deal
problem
recent
year
technolog
innov
involv
sequenc
independ
amplif
techniqu
next
gener
sequenc
ng
boost
viru
discoveri
ngsbase
techniqu
becom
standard
discoveri
viral
pathogen
clinic
sampl
among
innov
sequenc
independ
method
use
effici
identifi
unknown
virus
diagnost
virolog
one
method
viru
discoveri
base
cdna
amplifi
fragment
length
polymorph
vidisca
proven
success
tool
identif
unknown
virus
method
capabl
detect
dna
rna
virus
without
prior
knowledg
viral
famili
base
restrict
enzym
digest
nowaday
vidisca
combin
next
gener
sequenc
time
develop
success
use
discov
novel
virus
cell
cultur
like
human
coronaviru
human
parechoviru
type
human
parechoviru
type
variant
standard
vidisca
use
two
step
pcr
amplif
protocol
complex
second
select
amplif
round
subsequ
isol
pcr
fragment
uninfect
cultur
last
amplif
step
complex
labor
intens
need
distinguish
background
ribosom
rna
pcr
fragment
viral
pcr
product
howev
pretreat
sampl
prior
vidisca
significantli
optim
amplif
ribosom
rna
diminish
dramat
therefor
simplifi
vidisca
protocol
develop
lack
last
amplif
round
evalu
use
virus
cultur
stool
sampl
acut
flaccid
paralysi
children
remain
unrecogn
cell
cultur
enteroviru
specif
realtim
pcr
viru
discoveri
techniqu
often
combin
unbias
amplif
high
throughput
sequenc
howev
high
throughput
sequenc
almost
imposs
develop
countri
like
pakistan
cost
prohibit
therefor
use
simpl
cheap
altern
viru
discoveri
tool
combin
short
viru
cultur
togeth
simplifi
version
vidisca
overview
adapt
shown
addit
file
tabl
ten
supernat
cpeshow
cultur
stool
patient
acut
flaccid
paralysi
test
patient
characterist
shown
tabl
viru
cultur
examin
standard
diagnost
remain
neg
data
shown
studi
sampl
yield
pcr
fragment
metaphor
gel
figur
sampl
pcr
product
present
sampl
cell
cultur
control
cut
gel
clone
ecoli
twelv
clone
product
sanger
sequenc
signific
amount
nucleotid
sequenc
show
ident
known
virus
sampl
viral
sequenc
match
member
belong
differ
famili
eg
picornavirida
astrovirida
tabl
proport
eukaryot
viral
sequenc
sampl
vari
rang
four
human
enterovirus
identifi
serotyp
echoviru
e
human
parechoviru
type
one
human
astroviru
sever
fragment
ident
type
fragment
differ
locat
genom
show
ident
human
astroviru
type
character
virus
vidiscaposit
sampl
amplifi
sequenc
gene
specif
primer
human
enterovirus
parechoviru
gene
use
gene
use
astroviru
phylogenet
analys
gene
perform
investig
genet
relationship
human
enteroviru
strain
studi
paknih
enteroviru
serotyp
genbank
figur
nucleotid
ident
studi
strain
refer
prototyp
rang
within
serotyp
nucleotid
sequenc
ident
closest
rel
echoviru
farina
thu
isol
repres
separ
genotyp
match
close
strain
india
china
sweden
genbank
access
number
shown
figur
phylogenet
analysi
code
region
hpev
strain
avail
genbank
studi
isol
show
cluster
hpev
type
strain
isol
amsterdam
netherland
figur
strain
nucleotid
ident
amino
acid
ident
sequenc
astroviru
align
compar
sequenc
genbank
includ
gave
largest
similar
blast
align
genet
analysi
gene
serin
proteas
show
studi
isol
belong
human
astroviru
type
repres
nucleotid
ident
amino
acid
ident
hastv
isol
hand
genet
analysi
gene
capsid
protein
show
share
nucleotid
amino
acid
similar
hastv
type
isol
find
match
result
vidisca
conclud
astroviru
recombin
recombin
site
phylogenet
tree
construct
base
sequenc
gene
separ
show
differ
group
pattern
relat
refer
hastv
prototyp
figur
confirm
isol
probabl
recombin
figur
partial
nucleotid
sequenc
show
ident
strain
isol
afp
patient
afghanistan
figur
pairwis
distanc
calcul
show
nucleotid
ident
closest
match
therefor
probabl
present
diverg
isol
within
group
recent
year
sequenc
independ
pcr
approach
revolution
identif
unknown
novel
virus
either
alon
combin
convent
method
studi
simplifi
version
vidisca
use
detect
human
enterovirus
human
parechoviru
type
human
astroviru
cell
cultur
data
show
wide
rang
distinct
virus
remain
unrev
routin
assay
identifi
rel
short
amount
time
easi
use
method
vidisca
method
base
cdnaaflp
one
characterist
method
use
doubl
pcr
strategi
second
round
amplif
select
primer
select
pcrround
select
primer
extend
site
one
two
nucleotid
select
pcr
variou
combin
primer
use
order
amplifi
everyth
amplifi
first
pcr
select
pcr
step
complex
labori
step
vidisca
need
previous
distinguish
viral
pcr
fragment
ribosom
rna
amplicon
howev
improv
purif
revers
transcript
step
strongli
diminish
ribosom
rna
amplif
recent
publish
therefor
labori
select
amplif
step
might
need
show
major
viru
cultur
simplifiedvidisca
quickli
reveal
infect
agent
previous
publish
vidisca
origin
set
identifi
viru
picornaviruscultur
cultur
sensit
larg
compar
must
mention
compar
sensit
tradit
vidisca
simplifi
vidisca
directli
studi
possibl
failur
screen
studi
sampl
via
routin
assay
may
due
increas
genet
divers
pcr
prime
anneal
site
seven
virus
identifi
origin
stool
sampl
afp
patient
clinic
signific
virus
great
impact
public
health
constitut
health
risk
commun
isol
enterovirus
belong
enteroviru
b
speci
contain
frequent
isol
serotyp
commonli
caus
mening
myocard
neurolog
disord
enterovirus
caus
sever
potenti
lifethreaten
ill
current
antivir
treatment
avail
enteroviru
infect
phylogenet
cluster
studi
isol
reveal
enterovirus
relat
circul
strain
report
neighbor
countri
india
bangladesh
analysi
also
show
nucleotid
sequenc
echoviru
isol
paknih
low
nucleotid
ident
prototyp
farina
strain
fulfil
criterion
genotyp
therefor
suggest
separ
genotyp
circul
area
importantli
emerg
new
genet
lineag
enterovirus
commun
alarm
situat
pakistan
enteroviru
surveil
system
asid
polioviru
target
pathogen
polio
erad
strategi
nonpolio
enteroviru
detect
laboratori
partoutcom
afp
surveil
pakistan
despit
signific
number
isol
nonpolio
enterovirus
limit
inform
avail
regard
incid
divers
circul
pattern
consequ
right
time
prepar
futur
task
give
attent
toward
non
polio
virus
caus
afp
equal
caus
concern
approach
toward
polio
erad
era
similarli
hpev
known
caus
varieti
clinic
symptom
similar
enterovirus
like
gastroenter
occasion
flaccid
paralysi
enceph
particularli
infant
consid
major
caus
infant
mortal
worldwid
hpev
type
isol
stool
sampl
non
polio
afp
patient
year
age
studi
identifi
seven
month
old
paralyt
infant
fever
find
agreement
previou
studi
isol
children
age
less
three
year
transient
paralysi
sepsi
like
ill
astroviru
one
known
caus
acut
gastroenter
human
mostli
young
children
isol
earlier
stool
afp
patient
studi
astroviru
isol
six
month
old
child
follow
examin
day
indic
complet
recoveri
patient
paralysi
phylogenet
analys
base
gene
cluster
isol
two
differ
genotyp
genotyp
discrep
among
phylogenet
analysi
gene
like
repres
possibl
recombin
event
evolut
hastv
recombin
normal
phenomenon
among
virus
diverg
strain
type
tetnovirus
rna
viru
contain
two
larg
orf
encod
structur
nonstructur
protein
nonstructur
protein
contain
rna
depend
rna
polymeras
rdrp
cysteinelik
proteas
domain
genom
organ
close
relat
virus
classifi
famili
tetravirida
tetnovirus
close
relat
nodavirus
within
rdrp
protein
host
nodavirus
fish
arthropod
includ
insect
isol
earlier
futur
studi
need
identifi
origin
virus
clarifi
vitro
replic
pathogen
potenti
afp
children
nowaday
sequenc
independ
method
follow
high
throughput
sequenc
becom
promis
mean
detect
novel
pathogen
howev
highli
develop
technic
skill
involv
bioinformat
support
adequ
comput
resourc
advanc
data
interpret
high
cost
major
barrier
use
develop
resourcelimit
countri
exactli
region
outbreak
new
pathogen
like
occur
therefor
consid
adapt
vidisca
appropri
method
resourc
poor
countri
success
complet
limit
time
without
technic
difficulti
assay
applic
independ
laboratori
pcr
sequenc
facil
reproduc
easili
literatur
data
support
vidisca
may
great
util
identif
virus
escap
convent
diagnost
furthermor
avoid
cost
time
labor
use
special
equip
made
effici
power
diagnost
tool
resourc
poor
countri
final
find
also
provid
confid
improv
redesign
routin
diagnost
assay
might
lead
addit
detect
previous
undiagnos
virus
clinic
sampl
patient
total
ten
stool
sampl
afp
children
age
less
year
select
sampl
bank
acut
flaccid
paralysi
patient
virolog
depart
nation
institut
health
pakistan
tabl
sampl
show
cytopath
effect
cpe
rhabdomyasarcoma
cell
rd
mous
cell
receptor
human
poliovirus
found
neg
enteroviru
realtim
revers
transcript
pcr
target
genom
cell
cultur
control
rd
cell
includ
studi
approv
intern
review
board
nation
institut
health
pakistan
written
inform
consent
obtain
parent
guardian
particip
patient
pretreat
sampl
use
prior
vidisca
reduc
background
nucleic
acid
sampl
centrifug
g
supernat
digest
trubo
dnase
ambion
extract
isol
nucleic
acid
perform
accord
protocol
boom
et
al
revers
transcript
perform
use
random
hexamer
design
anneal
ribosom
rna
describ
endoh
et
al
klenow
polymeras
use
second
strand
synthesi
new
england
biolab
doubl
strand
dna
subsequ
digest
anneal
adaptor
describ
de
vri
et
al
follow
pcr
one
round
cycl
differ
protocol
describ
cookbook
version
method
present
addit
file
doc
sequenc
trim
raw
sequenc
data
use
sequench
program
version
gene
code
corpor
analyz
onlin
http
wwwncbinlmnihgovblast
blastn
blastx
algorithm
use
identifi
sequenc
similar
known
virus
genbank
sequenc
identifi
viral
classifi
viral
famili
base
taxonomi
best
hit
sampl
sequenc
ident
known
virus
character
gene
specif
pcr
confirm
presenc
pathogen
sampl
capsidencod
gene
human
enterovirus
human
parechoviru
type
amplifi
use
primer
respect
similarli
gene
human
astroviru
amplifi
use
primer
respect
amplifi
dna
product
visual
agaros
gel
sequenc
primer
use
pcr
phylogenet
analys
conduct
use
mega
molecular
evolutionari
genet
analysi
version
p
distanc
nucleotid
amino
acid
comput
tree
construct
neighbor
join
nj
method
use
kimura
model
nucleotid
sequenc
bootstrap
valu
pseudo
replic
data
set
estim
sequenc
studi
submit
genbank
access
number
addit
file
tabl
overview
adapt
vidisca
protocol
addit
file
doc
cookbook
version
simplifi
vidisca
method
author
declar
compet
interest
